ImmusanT, a biotechnology company out of Massachusetts is working on developing Nexxax2, a vaccine which could potentially treat or prevent celiac disease.  As of this week, they finished the Phase 1 b trial.  This means that we are now closer than ever to finding some sort of “cure” or treatment for celiac beyond the dietary […]